2026· Methods in molecular biology· Vol 3065, pp.
213-226
· 0 citations
Medicine
TL;DR
The utilization of the long circulation of serum albumin to increase the blood residence time of gapmer ASOs is described and a strategy to optimize gapmer ASO pharmacokinetics by a proposed endogenous assembly process with serum albumin that can be tuned by gapmer ASO design modifications is offered.
Conventional oligonucleotides, such as DNA and RNA, are extensively modified for therapeutic applications. The mixed-backbone oligonucleotides (MBOs) that are generated by combining different classes have superior properties such as enhanced mRNA binding affinity, improved distribution, and reduced toxicity. Oligonuc...
A sensitive enzyme-linked immunosorbent assay (ELISA)-based protocol is described that can be used to quantify the levels of locked nucleic acid (LNA) and 2'-O-methoxyethyl (2'-MOE) gapmers in mouse muscle tissue.
K. Lim, Q. Nguyen, T. Yokota· Methods in molecular biology· 0 citations
This review summarizes the current understanding of PTMs affecting human serum albumin, with particular emphasis on their molecular origins and functional implications, and examines established and emerging applications of PTM-modified albumin in diagnostics, critical care, extracorporeal detoxification, drug delivery,...
Roko Gladović, João G. Brás, J. Vollenbroek et al.· Toxins· 0 citations
Antisense oligonucleotides (ASOs) are potent therapeutics that enable precise RNA modulation. However, efficient delivery to tissues and cell types remains a major challenge. Multimerization, linking multiple ASOs to form large constructs, represents a promising strategy to explore delivery and pharmacokinetics modulat...
Quentin Vicentini, Elena Grobecker, D. Daniele et al.· Journal of Medicinal Chemist...· 0 citations
It is shown that introducing a pH-sensitive linker in C16 lipid- and C22 lipid-conjugated ASOs increases endosomal remodeling events detected via a Galectin 9 reporter imaging assay, despite similar levels of ASO cellular uptake, and incorporation of a pH-sensitive linker can lead to improved gene silencing in vitro.
Priyanka Mangla, Emma Kay, M. J. Munson et al.· Nucleic Acid Therapeutics· 0 citations